In conclusion, the lower levels of CD56 and CD117 expressions in advanced-stage disease and also the inverse relationship between LDH level and CD117 expression may support the importance of these expressions as prognostic markers in MM. The gene discussed is NCAM1; the disease is Miyoshi myopathy.